Maintenance therapy with hypomethylating agents for patients with acute myeloid leukemia in first remission not eligible for allogeneic hematopoietic cell transplantation: A system... von Sherban, A., Raanani, P., Gurion, R., Wolach, O., Gafter-Gvili, A.

Volltext

Safety and efficacy of FLAG-Ida-based therapy combined with venetoclax for the treatment for newly diagnosed and relapsed/refractory patients with AML – A systematic review von Sherban, A., Fredman, D., Shimony, S., Yeshurun, M., Raanani, P., Stahl, M., Gafter-Gvili, A., Wolach, O.

Volltext

Enteroviral infection in patients treated with rituximab for non‐Hodgkin lymphoma: a case series and review of the literature von Grisariu, S., Vaxman, I., Gatt, M., Elias, S., Avni, B., Arad, A., Pasvolsky, O., Raanani, P., Paltiel, O.

Volltext

Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-... von Yeshurun, M., Vaxman, I., Shargian, L., Yahav, D., Bishara, J., Pasvolsky, O., Wolach, O., Lahav, M., Gurion, R., Magen, H., Vidal, L., Herscovici, C., Peck, A., Moshe, M., Sela-Navon, M., Naparstek, E., Raanani, P., Rozovski, U.

Volltext

Prophylaxis regimens for GVHD: systematic review and meta-analysis von Ram, R, Gafter-Gvili, A, Yeshurun, M, Paul, M, Raanani, P, Shpilberg, O

Volltext

P1461: CAR‐T VS. STANDARD OF CARE AS SECOND LINE TREATMENT FOR LARGE B CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META‐ANALYSIS von Shargian, L., Raanani, P., Yeshurun, M., Gafter‐Gvili, A., Gurion, R.

Volltext

Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? von Raanani, P., Shasha, Y., Perry, C., Metser, U., Naparstek, E., Apter, S., Nagler, A., Polliack, A., Ben-Bassat, I., Even-Sapir, E.

Volltext

R‐CHOP VS. R‐CHOP+X FOR NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META‐ANALYSIS von Pasvolsky, O., Rozental, A., Raanani, P., Gafter‐Gvili, A., Gurion, R.

Volltext

P1166: REPEAT BIOPSY IN RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A NATIONWIDE SURVEY AND RETROSPECTIVE STUDY von Berger, T., Geiger, K. R., Yeshurun, M., Gafter‐Gvili, A., Shochat, T., Gurion, R., Raanani, P., Pasvolsky, O.

Volltext

Extramedullary disease and targeted therapies for hematological malignancies—is the association real? von Raanani, P., Shpilberg, O., Ben-Bassat, I.

Volltext

PREVALENCE AND CLINICAL SIGNIFICANCE OF HYPERCALCEMIA AT DIAGNOSIS IN DIFFUSE LARGE B CELL LYMPHOMA von Abadi, U., Peled, L., Rotman‐Pikielny, P., Raanani, P., Ellis, M.H., Rozovski, U., Gurion, R.

Volltext

P979: EXOSOMES IN POLYCYTHEMIA VERA: “MINI PLATELETS“ WITH THROMBOGENIC POTENTIAL von Abulafia, A., Spectre, G., Ziv, E., Geiger, K. R., Sarsor, Z., Ron, N., Beery, E., Revel‐Vilk, S., Naamad, M., Raanani, P., Uziel, O., Rozovski, U.

Volltext

P585: VENETOCLAX IN COMBINATION WITH INTENSIVE TREATMENT PROTOCOLS FOR PATIENTS WITH HIGH‐RISK ACUTE MYELOID LEUKEMIA – A MULTICENTER REAL‐WORLD ANALYSIS von Wolach, O., Frisch, A., Shargian, L., Yeshurun, M., Apel, A., Vainstein, V., Moshe, Y., Shimony, S., Amit, O., Bar On, Y., Ofran, Y., Raanani, P., Nachmias, B., Ram, R.

Volltext

P578: GILTERITINIB FOR RELAPSED/REFRACTORY FLT3 MUTATED ACUTE MYELOID LEUKEMIA A REAL‐WORLD, MULTI‐CENTER, MATCHED ANALYSIS von Shimony, S., Canaani, J., Kugler, E., Nachmias, B., Ram, R., Frisch, A., Ganzel, C., Vainstein, V., Moshe, Y., Aumann, S., Yeshurun, M., Ofran, Y., Raanani, P., Wolach, O.

Volltext

Does Bone Marrow Cellularity (BMC) Have a Role in Predicting Prognosis and Survival in Myelodysplastic Syndromes (MDS)? von Greenbaum, U, Joffe, E, Oster, H.S, Kirgner, I, Levi, I, Raanani, P, Avivi, I, Mittelman, M

Volltext

The role of maintenance therapy in patients with diffuse large B‐cell lymphoma: A systematic review and meta‐analysis von Rozental, A., Gafter‐Gvili, A., Vidal, L., Raanani, P., Gurion, R.

Volltext

THE VALUE OF PET/CT IN DETECTING BONE MARROW INVOLVEMENT IN PATIENTS WITH PERIPHERAL T‐CELL LYMPHOMA von Gurion, R., Bernstein, H., Vidal, L., Raanani, P., Gafter‐Gvili, A.

Volltext

PET‐CT–adapted therapy for advanced Hodgkin lymphoma: A systematic review of the literature von Amitai, I., Gurion, R., Vidal, L., Dann, E.J., Raanani, P., Gafter‐Gvili, A.

Volltext

P1203: THE OPTIMIZED HLH INFLAMMATORY (OHI) INDEX IDENTIFIES LYMPHOMA PATIENTS WITH UNEXPECTEDLY HIGH MORTALITY NOT RELATED TO DISEASE PROGRESSION von Zoref‐Lorenz, A., Murakami, J., Hofstetter, L., Abadi, U., Iyer, S., Mohamed, S., Miller, P. G., Natour, A. E. H., Weinstein, S., Yacobovich, J., Izraeli, S., Nikiforow, S., Ebert, B., Gurion, R., Cohen, I., Pasvolsky, O., Raanani, P., Nagler, A., Berliner, N., Daver, N., Ellis, M., Jordan, M.

Volltext

P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS von Gurion, R., Rozovski, U., Itchaki, G., Gafter‐Gvili, A., Leibovitch, C., Raanani, P., Szwarcwort, M., Taylor‐Abigadol, M., Dann, E., Horesh, N., Inbar, T., Tzoran, I., Lavi, N., Bar Haim, E., Cohen, H., Slouzky, I., Azoulay, T., Karmona, M., Ringelstein‐Harlev, S., Horowitz, N. A.

Volltext